Contact

Our portfolio

Haermonics

Innovating post-surgery care, Haermonics develops a device to flush and clean the pericardial space, preventing blood-related complications after open-heart surgery. Their technology reduces the risk of blood clots and subsequent operations. The company is dedicated to improving surgical outcomes through advanced medical devices.

  • Institute: Amsterdam UMC
Industry: Cardiology, Medical Technology, Surgery
  • Founding year: 2015
Visit website

Want to get in contact about Haermonics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

PsyPhy
Developing portable neurophysiological research tools for EEG and behavioral studies.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.

Cellagenics

Cellagenics
Scaling up therapeutic antibody production with STEP® technology.
PsyPhy
Developing portable neurophysiological research tools for EEG and behavioral studies.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.

Cellagenics

Cellagenics
Scaling up therapeutic antibody production with STEP® technology.
Explore full AAV portfolio
Contact